Regulatory29 Aug 2026, 06:40 pm
Sampre Nutritions Gets BSE Approval for Share Issuance
AI Summary
Sampre Nutritions Limited has received in-principle approval from the BSE for the issuance and allotment of 1,770,710 equity shares of INR 5 each at a price of not less than INR 42 each. These shares will be issued to the promoter and promoter group on a preferential basis, converting unsecured loans aggregating to INR 7,43,69,820. The company has been advised to strengthen internal controls and obtain undertakings from allottees regarding trading restrictions to ensure compliance with SEBI regulations.
Key Highlights
- BSE grants in-principle approval for preferential share issuance.
- 1,770,710 equity shares to be issued to promoters.
- Conversion of unsecured loans worth ₹7.43 Cr into equity.
- Shares to be issued at a minimum price of ₹42 each.
- Company must comply with SEBI regulations and strengthen controls.
Price Impact
More from SAMPRE